News Sentiment

COSM sentiment intelligence

Cosmos Health Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 60 Balanced news tone 64 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Distribution Read-through group
Latest close 0.29 Week of 10 Jul 2026
Weighted tone 60/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Capital return

74/100 classification confidence.

Company focus 64

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+23.5% over one week, +39.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Cosmos Health (NASDAQ: COSM) wins backing for Series B preferred and equity plan

Market Reaction

Price moving ahead of tone

68/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Capital return 74/100 classification
One-week reaction 23.5% Price confirming higher
Trend fit Trend inactive 39.4% over four weeks
Fair value -61.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 28
Neutral 36
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 64
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 18
GlobeNewswire 8
Investing.com 7
GuruFocus 6
TradingView 5
Quiver Quantitative 3
Investing.com Canada 2
Moomoo 2

Event Lens

What the news is about

Classified themes
Capital return 26
Market update 21
Earnings 13
Deals and strategy 2
Macro sensitivity 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 64
TradingView Direct company coverage

Price to book forward of Cosmos Health Inc – SWB:V67A

This article provides a brief snapshot of the "Price to book forward" for Cosmos Health Inc (SWB:V67A) on the Stuttgart Stock Exchange. It indicates that the market was closed at the time of publication, with no trades reported. The content primarily highlights the financial metr

Tone
Neutral 50/100
Event
Market update
Published
16 Jul 2026 12:39
Source
TradingView
Investing.com Direct company coverage

Cosmos Health repurchases 100,000 shares at $0.29 average

Cosmos Health Inc. has repurchased 100,000 shares of its common stock at an average price of $0.2928 per share, bringing the total repurchases under its $5 million program to 4,588,000 shares. The company's CEO, Greg Siokas, emphasized commitment to the program, which is set to e

Tone
Positive 75/100
Event
Market update
Published
15 Jul 2026 19:11
Source
Investing.com
Quiver Quantitative Direct company coverage

Cosmos Health Inc. Repurchases Additional 100,000 Shares, Surpasses 4.5 Million Shares Buyback Total

Cosmos Health Inc. announced it repurchased an additional 100,000 shares of its common stock, bringing the total under its $5 million buyback program to 4,588,000 shares for approximately $970,000. CEO Greg Siokas affirmed confidence in the program, which extends until December 3

Tone
Positive 70/100
Event
Capital return
Published
15 Jul 2026 18:20
Source
Quiver Quantitative
Stock Titan Direct company coverage

Cosmos Health Has Spent About $970K on Open-Market Buybacks

Cosmos Health (NASDAQ: COSM) has repurchased an additional 100,000 shares of its common stock, bringing the total to 4,588,000 shares, for approximately $970,000 under its $5 million share repurchase program. The company continues to make open-market repurchases and the program i

Tone
Positive 67/100
Event
Capital return
Published
15 Jul 2026 18:11
Source
Stock Titan
Moomoo Direct company coverage

Cosmos Health: Share Buyback Expands to 4.5M Shares

This article announces that Cosmos Health (COSM) has expanded its share buyback program from 1 million to 4.5 million shares, representing approximately 10% of its total outstanding shares. The company aims to enhance shareholder value through this move, with the shares primarily

Tone
Positive 68/100
Event
Capital return
Published
14 Jul 2026 20:11
Source
Moomoo
Via Ritzau Direct company coverage

Cosmos Health Inc. Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases

Cosmos Health Inc. announced it has repurchased an additional 133,000 shares of its common stock, bringing the total to approximately 4.49 million shares for $941,000 under its $5 million share repurchase program. The company intends to continue open market repurchases, reflectin

Tone
Positive 75/100
Event
Capital return
Published
14 Jul 2026 19:05
Source
Via Ritzau
Investing.com Direct company coverage

Cosmos Health repurchases 133,000 shares at average $0.298

Cosmos Health Inc. has repurchased 133,000 shares of its common stock at an average price of $0.298 per share, bringing the total repurchased under its program to 4,488,000 shares for $941,000. CEO Greg Siokas expressed confidence in the company's long-term growth, viewing the sh

Tone
Positive 66/100
Event
Market update
Published
14 Jul 2026 19:05
Source
Investing.com
Stock Titan Direct company coverage

Cosmos Health Intends to Keep Buying Shares Under $5M Plan

Cosmos Health (NASDAQ:COSM) has repurchased an additional 133,000 common shares at about $0.298 per share, bringing the total under its buyback program to 4,488,000 shares for $941,000. The company plans to continue open market repurchases under a $5 million authorization that ru

Tone
Positive 59/100
Event
Capital return
Published
14 Jul 2026 19:05
Source
Stock Titan
Investing.com Direct company coverage

Cosmos Health repurchases 215,000 shares at $0.325 average

Cosmos Health Inc. has repurchased an additional 215,000 shares of its common stock at an average price of $0.325 per share, bringing the total repurchased shares to 4,355,000 for approximately $901,000 under its $5 million share repurchase program. The CEO, Greg Siokas, believes

Tone
Positive 70/100
Event
Capital return
Published
14 Jul 2026 03:05
Source
Investing.com
Kavout | AI Direct company coverage

Cosmos Health's Bold Buyback: A Conviction Play or a Risky Bet?

Cosmos Health (NASDAQ: COSM) has aggressively repurchased 4.36 million shares, signaling management's belief that the stock is undervalued, despite its sub-$0.50 price. The company projects a significant financial turnaround by 2029, aiming for $200.6 million in revenue and $31.0

Tone
Neutral 50/100
Event
Earnings
Published
13 Jul 2026 22:42
Source
Kavout | AI
Via Ritzau Direct company coverage

Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases

Cosmos Health Inc. announced that its share buyback program has reached a total of 4.36 million shares repurchased for approximately $901,000. The company bought an additional 215,000 shares at about $0.325 each and plans to continue open market repurchases under the program, whi

Tone
Positive 72/100
Event
Capital return
Published
13 Jul 2026 18:42
Source
Via Ritzau
Quiver Quantitative Direct company coverage

Cosmos Health Repurchases Additional 215,000 Shares Under $5 Million Buyback Program

Cosmos Health Inc. has repurchased an additional 215,000 shares of its common stock, bringing the total to 4,355,000 shares under its $5 million buyback program. The repurchase, at an average price of $0.325 per share, reflects CEO Greg Siokas' belief that the company's shares ar

Tone
Positive 65/100
Event
Capital return
Published
13 Jul 2026 18:10
Source
Quiver Quantitative
Stock Titan Direct company coverage

Why Cosmos Health is still buying back its own stock at 32¢ a share

Cosmos Health (NASDAQ: COSM) has repurchased an additional 215,000 shares at an average price of $0.325 per share, bringing the total under its buyback program to 4,355,000 shares for approximately $901,000. The program, authorized for up to $5 million, runs until December 31, 20

Tone
Positive 63/100
Event
Capital return
Published
13 Jul 2026 18:00
Source
Stock Titan
Investing.com Direct company coverage

Cosmos Health partners with Libytec for diabetes drug in Greece

Cosmos Health Inc. has entered a five-year agreement with Libytec Pharmaceutical S.A. to commercialize DIABIT-IS X, a type-2 diabetes medication, in Greece. Cosmos Health, through its subsidiary Cana Laboratories, will supply the drug, while Libytec handles distribution and promo

Tone
Positive 78/100
Event
Macro sensitivity
Published
13 Jul 2026 16:42
Source
Investing.com
Stock Titan Direct company coverage

Generic rival to Merck’s Januvia set for Greek rollout via Cosmos–Libytec deal

Cosmos Health announced a five-year agreement with Libytec Pharmaceutical to commercialize its type-2 diabetes medicine, DIABIT-IS X (sitagliptin phosphate), in Greece. This generic alternative to Merck's Januvia is expected to contribute significantly to Cosmos Health's revenue

Tone
Positive 70/100
Event
Earnings
Published
13 Jul 2026 16:42
Source
Stock Titan
TradingView Direct company coverage

Price to earnings forward of Cosmos Health Inc – SWB:V67A

This article provides financial information for Cosmos Health Inc (SWB:V67A) on TradingView, specifically focusing on its forward price-to-earnings ratio. It indicates that the market was closed when the data was accessed, showing no trades. The content primarily acts as a placeh

Tone
Neutral 50/100
Event
Earnings
Published
13 Jul 2026 15:42
Source
TradingView
TradingView Direct company coverage

Cost of goods sold of Cosmos Health Inc – HAM:V67A

This article displays the "Cost of goods sold" for Cosmos Health Inc (HAM:V67A) on the Hamburg Stock Exchange via TradingView. It indicates that no trades have occurred for this specific financial metric. The content primarily focuses on company financials and various data source

Tone
Neutral 50/100
Event
Market update
Published
12 Jul 2026 12:39
Source
TradingView